Financhill
Sell
18

XXII Quote, Financials, Valuation and Earnings

Last price:
$1.70
Seasonality move :
-1.16%
Day range:
$1.69 - $1.75
52-week range:
$1.68 - $581.85
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.00x
P/B ratio:
0.27x
Volume:
53.5K
Avg. volume:
85.4K
1-year change:
-99.41%
Market cap:
$946.5K
Revenue:
$32.2M
EPS (TTM):
-$8,358.46

Earnings Data

Next earnings date for XXII
May 15
2025
Most recent earnings per share
-$12.91
Missed by $12.91
(Mar 20/2025)
Consensus Estimate
--
(Mar 20/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

XXII Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/20/2025 Q4 -- $1.8M -$12.91 -- --
11/12/2024 Q3 -- $2.5M -$74.25 -- --
08/13/2024 Q2 -- $4.4M -$28.35 -- --
05/15/2024 Q1 $7.9M $3.1M -$396.90 -- --
03/28/2024 Q4 $18.7M $19.7M -$1,905.46 -- --
11/06/2023 Q3 $20.3M $4M -$8,201.25 -$2,073.60 -$6,127.65
08/14/2023 Q2 $24.3M $3.7M -$3,214.35 -$2,268.00 -$946.35
05/09/2023 Q1 $20M $4.7M -$2,714.14 -$2,430.00 -$284.14
03/09/2023 Q4 $20.1M -$2.4M -$3,888.00 -$1,944.00 -$1,944.00
11/08/2022 Q3 $20.5M $19.4M -$2,030.40 -$1,944.00 -$86.40
08/09/2022 Q2 $11.3M $14.5M -$2,051.99 -$1,863.00 -$188.99
05/05/2022 Q1 $8.3M $9M -$1,620.00 -$2,592.00 $972.00
03/01/2022 Q4 -- $8M -$2,916.00 -- --
11/04/2021 Q3 -- $7.8M -$1,944.00 -- --
08/05/2021 Q2 -- $8.4M -$972.00 -- --
05/06/2021 Q1 -- $6.8M -$972.00 -- --
03/11/2021 Q4 -- $7.3M -$1,296.00 -- --
11/05/2020 Q3 -- $7.3M -$972.00 -- --
08/06/2020 Q2 -- $6.4M -$1,296.00 -- --
05/07/2020 Q1 -- $7.1M -$972.00 -- --
12/31/2019 Q4 -- $7.3M -$1,620.00 -- --
09/30/2019 Q3 -- $6.5M -$2,592.00 -- --
06/30/2019 Q2 -- $5.8M -$1,944.00 -- --
03/31/2019 Q1 -- $6.3M -$648.00 -- --
12/31/2018 Q4 -- $7.1M -$2,268.00 -- --
11/07/2018 Q3 -- $6.3M $1,296.00 -- --
06/30/2018 Q2 -- $6.9M -$1,620.00 -- --
03/31/2018 Q1 -- $6.1M $324.00 -- --
12/31/2017 Q4 -- $5.9M -$972.00 -- --
09/30/2017 Q3 -- $4.5M -$972.00 -- --
06/30/2017 Q2 -- $3.9M -$1,296.00 -- --
05/08/2017 Q1 -- $2.2M -$972.00 -- --
03/09/2017 Q4 -- $3.3M -$1,296.00 -- --
11/09/2016 Q3 -- $3.1M -$972.00 -- --
08/10/2016 Q2 -- $2.8M -$1,296.00 -- --
05/09/2016 Q1 -- $3M -$1,296.00 -- --
03/11/2016 Q4 -- $2.9M -$1,296.00 -- --
11/13/2015 Q3 -- $2.7M -$1,296.00 -- --
08/05/2015 Q2 -- $2.3M -$648.00 -- --
05/15/2015 Q1 -- $616.1K -$1,944.00 -- --

22nd Century Group Earnings Questions

  • How Much did 22nd Century Group Generate in Revenue Last Quarter?

    22nd Century Group reported $1.8M worth of top line sales in its most recent quarter.

  • Did 22nd Century Group Beat Earnings Last Quarter?

    22nd Century Group announced earnings per share of -$12.91 which represents a miss of analyst forecast a -- per share.

  • Is 22nd Century Group Profitable?

    22nd Century Group reported -$588K that represents -$5.88 per share over the last quarter.

  • What is the Analyst Consensus for 22nd Century Group EPS Next Year?

    22nd Century Group's earnings are forecast to decrease from -$15,724.80 per share to -- per share next year representing a decrease of -7.31%.

  • When is 22nd Century Group's Earnings Date?

    22nd Century Group's next earnings date is May 15, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Progressive Stock Go Down?
Why Did Progressive Stock Go Down?

Shares of insurance giant Progressive (NYSE:PGR) have fallen considerably over…

Why Did StoneCo Stock Go Up So Much?
Why Did StoneCo Stock Go Up So Much?

Brazilian fintech company StoneCo (NASDAQ:STNE) has been on a tear…

Is Tenable Stock a Buy, Sell or Hold?
Is Tenable Stock a Buy, Sell or Hold?

Tenable (NASDAQ:TENB) is a cybersecurity company with a focus on…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3T
P/E Ratio: 41x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Sell
47
RGC alert for Mar 25

Regencell Bioscience Holdings [RGC] is down 28.36% over the past day.

Buy
58
TNXP alert for Mar 25

Tonix Pharmaceuticals Holding [TNXP] is up 32.39% over the past day.

Buy
54
AZEK alert for Mar 25

The AZEK [AZEK] is up 17.3% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock